Description
Zanamivirisanantiviralneuraminidaseinhibitorthatisusedclinicallytotreatinfluenzavirusinfection.ZanamivirmayalsoshowsomeinhibitoryactivityagainstRNAvirusinfectionsaswell.
Zanamivirisanantiviralneuraminidaseinhibitorthatisusedclinicallytotreatinfluenzavirusinfection.ZanamivirmayalsoshowsomeinhibitoryactivityagainstRNAvirusinfectionsaswell.
CasNo. | 139110-80-8 |
---|---|
Purity | ≥98% |
Formula | C12H20N4O7 |
FormulaWt. | 332.31 |
IUPACName | (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylicacid |
Synonym | 5-acetamido-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylicacid |
Appearance | Whitetooffwhitepowder |
StoreTemp | Ambient |
---|---|
ShipTemp | Ambient |
InfoSheet | Z0252InfoSheetPDF |
---|
KimJH,ResendeR,WennekesT,etal.Mechanism-basedcovalentneuraminidaseinhibitorswithbroad-spectruminfluenzaantiviralactivity.Science.2013Apr5;340(6128):71-5.PMID:23429702.
LeyssenP,DeClercqE,NeytsJ.MolecularstrategiestoinhibitthereplicationofRNAviruses.AntiviralRes.2008Apr;78(1):9-25.PMID:18313769.